Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
e-Letters: Observations

Bariatric Surgery in Patients With Obesity and Latent Autoimmune Diabetes in Adults (LADA)

  1. Ali Aminian1⇑,
  2. Gautam Sharma1,
  3. Rickesha L. Wilson1,
  4. Sangeeta R. Kashyap2,
  5. Emanuele Lo Menzo3,
  6. Samuel Szomstein3,
  7. Raul J. Rosenthal3,
  8. Philip R. Schauer4 and
  9. Roman Vangoitsenhoven1,5
  1. 1Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic, Cleveland, OH
  2. 2Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH
  3. 3Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic Florida, Weston, FL
  4. 4Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA
  5. 5Department of Endocrinology, UZ Leuven, Leuven, Belgium
  1. Corresponding author: Ali Aminian, aminiaa{at}ccf.org
Diabetes Care 2020 May; 43(5): e56-e57. https://doi.org/10.2337/dc19-2388
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Bariatric surgery induces weight loss and restores glucose metabolism in patients with obesity and type 2 diabetes (T2D) (1). In patients with autoimmune diabetes that eventually results in β-cell failure, the glycemic effects of bariatric surgery are limited (2). Adult patients with latent autoimmune diabetes in adults (LADA) have a slower decline in β-cell function and lower requirement for insulin therapy than patients with classical young-onset type 1 diabetes (T1D) (3). They are often misdiagnosed as having T2D and might have unrealistic expectations of diabetes remission after bariatric surgery with additional risk for development of postoperative diabetic ketoacidosis (DKA) (4). The safety and efficacy of bariatric surgery in patients with obesity and LADA have not been characterized.

We retrospectively analyzed medical records of patients with obesity and LADA who underwent bariatric surgery at the Cleveland Clinic Health System in the U.S. LADA status was defined as adult-onset diabetes with presence of GAD antibodies. We compared pre- and postsurgery BMI, glycemic control (HbA1c), daily insulin dose, and blood pressure and lipid profile using a paired Student t test, with a P value of 0.05 considered significant.

Between October 2006 and March 2018, nine female patients underwent laparoscopic bariatric surgery (five Roux-en-Y gastric bypass and four sleeve gastrectomy) and one male patient underwent sleeve gastrectomy. The median age at time of surgery was 52 years (range 40–66), with a median diabetes duration of 12 years (range 4–31). All 10 patients had elevated GAD antibodies, and only 2 patients had a detectable C-peptide at the time of surgery.

Preoperatively, the median BMI was 38.6 kg/m2 (range 34.8–53.7), the mean ± SD HbA1c was 9.4 ± 1.7% (79 ± 18.6 mmol/mol), and average insulin use was 0.84 ± 0.50 IU/kg/day. Figure 1 shows the evolution of BMI, HbA1c, and daily insulin requirement before and after surgery. One year postoperatively, BMI decreased to mean ± SD 30.3 ± 3.8 kg/m2 (P = 0.004) and daily insulin lowered to 0.52 ± 0.27 IU/kg (P = 0.019), but the HbA1c did not change significantly (8.6 ± 1.2% [70 ± 14 mmol/mol], P = 0.24). At the last follow-up (median 62 months, range 8–138), the weight loss persisted (BMI 33.1 ± 6.6 kg/m2, P = 0.01) and the HbA1c remained unchanged compared with baseline (9.0 ± 1.5% [75 ± 16.4 mmol/mol], P = 0.48). All patients had HbA1c >7% at the last follow-up. There were no significant changes in LDL (10 ± 45 mg/dL), HDL (6 ± 12 mg/dL), triglycerides (−13 ± 72 mg/dL), systolic blood pressure (2 ± 31 mmHg), or diastolic blood pressure (−6 ± 20 mmHg) following surgery. Two patients with pre-existing albuminuria showed regression after surgery: urinary albumin-to-creatinine ratio decreased from 329 to 66 mg/g and from 183 to 27 mg/g. Four patients developed DKA (postoperative day [POD] 0, 8, 9, and 16). One patient was diagnosed with deep venous thrombosis on POD 9 and one patient with an anastomotic ulcer on POD 30.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Changes in BMI (kg/m2) (A), HbA1c (%) (B), and daily insulin requirement (C and D) before and after bariatric surgery in patients with obesity and LADA. Data are presented as mean ± SEM. Number of patients with data at each time point is shown beneath x-axis. *P < 0.05.

This is the first case series describing the metabolic outcomes associated with bariatric surgery in patients with LADA. As expected, bariatric surgery induced major weight loss, accompanied by reduction in daily insulin requirement per kilogram body weight, presumably as a marker for reduced postoperative insulin resistance. There was no statistically significant improvement in glycemic control after surgery in this cohort of 10 patients with LADA, which is in contrast to the large reduction in HbA1c that is seen after bariatric surgery in the majority of patients with T2D (1). A numerical HbA1c reduction of 0.9% in the 1st year after surgery might be clinically relevant, but thorough assessment of diabetes subtype before considering bariatric surgery is warranted. Recently, the importance of identifying subgroups of diabetes to tailor treatment was highlighted (5). Our data suggest that the reduced residual β-cell capacity before surgery limits the improvement of glycemic control after bariatric surgery in patients with LADA, similar to observation in many patients with T1D (2). Moreover, patients with LADA have an elevated risk associated with surgery, as shown by development of DKA in the 1st postoperative month in 4 out of 10 patients in the current series. In insulin-deficient patients, surgical stress, abrupt discontinuation of insulin or inadequate management in the perioperative period, postoperative infection, and prolonged poor oral intake and dehydration would be the potential causes for postbariatric surgery DKA (6).

Furthermore, we could not detect beneficial changes in cardiovascular risk markers in this patient cohort, which is contrary to findings in the general bariatric population (1) and might be due to the small cohort size and lack of power. Although LADA status was defined as adult-onset diabetes with presence of GAD antibodies, this retrospective series might have included patients with T1D and T2D.

In conclusion, bariatric surgery induces weight loss and reduces daily insulin requirement in patients with LADA, but the current study did not show improvement in glycemic control. Recognizing different subtypes of diabetes is warranted when considering bariatric surgery for treatment of diabetes, including awareness for specific postoperative complications such as DKA. The main reason for considering bariatric surgery in patients with LADA should be treatment of severe obesity and potentially its multitude of comorbid conditions, not primarily for better glycemic control.

Article Information

Funding. R.V. was supported by a fellowship of the Fulbright Commission and a fellowship of the Belgian American Educational Foundation.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. A.A. and R.V. designed the study and contributed to data acquisition, data analysis and interpretation, literature search, and writing of the manuscript. G.S. and R.L.W. contributed to data collection. All authors reviewed the manuscript and edited it for intellectual content and gave final approval for this version to be published. A.A. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

  • Received November 27, 2019.
  • Accepted February 1, 2020.
  • © 2020 by the American Diabetes Association
https://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Schauer PR,
    2. Bhatt DL,
    3. Kirwan JP, et al.; STAMPEDE Investigators
    . Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med 2017;376:641–651
    OpenUrlCrossRefPubMed
  2. ↵
    1. Kirwan JP,
    2. Aminian A,
    3. Kashyap SR,
    4. Burguera B,
    5. Brethauer SA,
    6. Schauer PR
    . Bariatric surgery in obese patients with type 1 diabetes. Diabetes Care 2016;39:941–948
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Buzzetti R,
    2. Zampetti S,
    3. Maddaloni E
    . Adult-onset autoimmune diabetes: current knowledge and implications for management. Nat Rev Endocrinol 2017;13:674–686
    OpenUrlPubMed
  4. ↵
    1. Manning SB,
    2. Pucci A,
    3. Batterham RL,
    4. Finer N
    . Latent autoimmune diabetes in adults presenting as diabetes “recurrence” after bariatric surgery: a case report. Diabetes Care 2013;36:e120
    OpenUrlFREE Full Text
  5. ↵
    1. Ahlqvist E,
    2. Storm P,
    3. Käräjämäki A, et al
    . Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018;6:361–369
    OpenUrlPubMed
  6. ↵
    1. Aminian A,
    2. Kashyap SR,
    3. Burguera B, et al
    . Incidence and clinical features of diabetic ketoacidosis after bariatric and metabolic surgery. Diabetes Care 2016;39:e50–e53
    OpenUrlFREE Full Text
View Abstract
PreviousNext
Back to top
Diabetes Care: 43 (5)

In this Issue

May 2020, 43(5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bariatric Surgery in Patients With Obesity and Latent Autoimmune Diabetes in Adults (LADA)
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Bariatric Surgery in Patients With Obesity and Latent Autoimmune Diabetes in Adults (LADA)
Ali Aminian, Gautam Sharma, Rickesha L. Wilson, Sangeeta R. Kashyap, Emanuele Lo Menzo, Samuel Szomstein, Raul J. Rosenthal, Philip R. Schauer, Roman Vangoitsenhoven
Diabetes Care May 2020, 43 (5) e56-e57; DOI: 10.2337/dc19-2388

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Bariatric Surgery in Patients With Obesity and Latent Autoimmune Diabetes in Adults (LADA)
Ali Aminian, Gautam Sharma, Rickesha L. Wilson, Sangeeta R. Kashyap, Emanuele Lo Menzo, Samuel Szomstein, Raul J. Rosenthal, Philip R. Schauer, Roman Vangoitsenhoven
Diabetes Care May 2020, 43 (5) e56-e57; DOI: 10.2337/dc19-2388
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Comparison of Diagnostic Accuracy for Lower-Extremity Amputation Codes During the ICD-9 and ICD-10 Eras in a High-Risk Population of Patients With Diabetes
  • DPP-4 Inhibitors and Respiratory Infection: A Systematic Review and Meta-analysis of the Cardiovascular Outcomes Trials
  • Changes in Cardiovascular Biomarkers Associated With the Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes
Show more e-Letters: Observations

Similar Articles

Subjects

  • Obesity-Human

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.